Table 3.

The percentage of injection dose per gram (%ID/g) of the ¹¹¹ln-cyclic RGDfK-liposome or the ¹¹¹ln-liposome in lymph nodes and the radioactivity proportion of lymph nodes to blood in the mice without human melanoma xenotransplantation.

	Drug	111ln-Cyclic RGDfK-Liposome	111ln-Liposome
Item
jejunal lymph node (%ID/g)		2.1 ± 0.1	2.3 ± 00.09
inguinal lymph node (%ID/g)		0.5 ± 00.01	0.7 ± 0.1
axillary lymph node (%ID/g)		0.7 ± 0.12	1.2 ± 00.09
blood (%ID/g)		1.1 ± 00.05	1.3 ± 00.07
lymph node-to-blood ratio	jejunal to blood	1.9	1.7
	inguinal to blood	0.45	0.5
	axillary to blood	0.6	0.9